secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2024-03-29T23:59:59+00:00
Accession:  0001437749-24-010044
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq issues delist determination for Avenue Therapeutics; extension to May 20 granted
--------------------------------------------------------------------------------

- Nasdaq Staff issued delist determination on March 26, 2024 for failing Bid Price Rule ($1.00 minimum).
- Company did not regain compliance by March 25, 2024 end of 180-day grace period.
- Nasdaq Hearings Panel granted extension through May 20, 2024; delist notice has no immediate effect.
- Company evaluating options to regain compliance but no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000143774924010044/0001437749-24-010044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000143774924010044/atxi20240326c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-010044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer